About Kenneth Drazan
Form D filings for Arsenal Biosciences from 2022 to 2024 list Kenneth Drazan as executive officer and director.
Kenneth Drazan first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Kenneth Drazan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kenneth Drazan works with at each company, as listed on that company's latest Form D.
Arsenal Biosciences, Inc. · Form D, Sep 4, 2024
MF
Matthew Fust
Director
VB
Valentin Barsan
Director
SP
Sean Parker
Director
BB
Brook Byers
Director
JA
James Ahlers
Executive officer
IP
Irene Pleasure
Secretary
BS
Beth Seidenberg
Director